Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Drugs, impotence and infertility].
Fasolis G, Colombo M, Tarabuzzi R, Fontana D. Fasolis G, et al. Among authors: tarabuzzi r. Arch Ital Urol Nefrol Androl. 1991 Dec;63(4):397-401. Arch Ital Urol Nefrol Androl. 1991. PMID: 1686504 Italian.
Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P).
Berruti A, Cerutti S, Fasolis G, Sperone P, Tarabuzzi R, Bertetto O, Pagani G, Zolfanelli R, Pallotti S, Bumma C, Fontana D, Rosseti SR, Dogliotti L, Angeli A. Berruti A, et al. Among authors: tarabuzzi r. Anticancer Res. 1997 Nov-Dec;17(6D):4697-702. Anticancer Res. 1997. PMID: 9494591 Clinical Trial.
Randomized comparison of goserelin acetate versus mitomycin C plus goserelin acetate in previously untreated prostate cancer patients with bone metastases.
Fontana D, Bertetto O, Fasolis G, Berruti A, Tarabuzzi R, Pagani G, Buniva T, Zolfanelli R, Pallotti S, Frezzotti L, Bumma C, Rossetti SR, Dogliotti L. Fontana D, et al. Among authors: tarabuzzi r. Tumori. 1998 Jan-Feb;84(1):39-44. doi: 10.1177/030089169808400108. Tumori. 1998. PMID: 9619712 Clinical Trial.
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up.
Berruti A, Fara E, Tucci M, Tarabuzzi R, Mosca A, Terrone C, Gorzegno G, Fasolis G, Tampellini M, Porpiglia F, De Stefanis M, Fontana D, Bertetto O, Dogliotti L; Gruppo Onco-Urologico Piemontese, Rete Oncologica Piemontese. Berruti A, et al. Among authors: tarabuzzi r. Urol Oncol. 2005 Jan-Feb;23(1):1-7. doi: 10.1016/j.urolonc.2004.06.003. Urol Oncol. 2005. PMID: 15885575 Clinical Trial.
33 results